A Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina

por Depre, Christophe, Antalik, Lubomir, Starling, Amaal, Koren, Michael, Eisele, Osaro, Lenz, Robert A., Mikol, Daniel D.
Publicado 2018

A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia

por Gault, Laura M., Ritchie, Craig W., Robieson, Weining Z., Pritchett, Yili, Othman, Ahmed A., Lenz, Robert A.
Publicado 2015

ABT-126 monotherapy in mild-to-moderate Alzheimer’s dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension

por Gault, Laura M., Lenz, Robert A., Ritchie, Craig W., Meier, Andreas, Othman, Ahmed A., Tang, Qi, Berry, Scott, Pritchett, Yili, Robieson, Weining Z.
Publicado 2016

The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving ≥50%, ≥75%, and 100% Response

por Broessner, Gregor, Reuter, Uwe, Bonner, Jo H., Dodick, David W., Hallström, Yngve, Picard, Hernan, Zhang, Feng, Lenz, Robert A., Klatt, Jan, Mikol, Daniel D.
Publicado 2020

Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial

por Tepper, Stewart J., Diener, Hans-Christoph, Ashina, Messoud, Brandes, Jan Lewis, Friedman, Deborah I., Reuter, Uwe, Cheng, Sunfa, Nilsen, Jon, Leonardi, Dean K., Lenz, Robert A., Mikol, Daniel D.
Publicado 2019

One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study

por Goadsby, Peter J., Reuter, Uwe, Hallström, Yngve, Broessner, Gregor, Bonner, Jo H., Zhang, Feng, Wright, Ian K., Chou, Denise E., Klatt, Jan, Picard, Hernan, Lenz, Robert A., Mikol, Daniel D.
Publicado 2020